InnovAge Holding Corp. Investing Cash Flow
InnovAge Holding Corp. (INNV) reported Investing Cash Flow of -$12.34 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-09-09
- InnovAge Holding Corp. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$4.82M, a 593.85% decline year-over-year.
- InnovAge Holding Corp. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$3.80M.
- InnovAge Holding Corp. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$2.90M, a 166.02% decline year-over-year.
- InnovAge Holding Corp. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$814.00K.
- InnovAge Holding Corp. net cash provided by (used in) investing activities for fiscal 2026 was -$12.34M.
- InnovAge Holding Corp. net cash provided by (used in) investing activities for fiscal 2025 was -$5.55M.
- InnovAge Holding Corp. net cash provided by (used in) investing activities for fiscal 2024 was -$26.37M.
- InnovAge Holding Corp. net cash provided by (used in) investing activities for fiscal 2023 was -$69.52M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | -$8.62M derived: sum of 2 quarters · filed 2026-09-09 | -$11.53M derived: sum of 3 quarters · filed 2026-09-09 | -$12.34M 10-K · filed 2026-09-09 |
| 2026-03-31 | -$3.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | -$6.71M derived: sum of 2 quarters · filed 2026-05-08 | -$7.52M 10-Q · filed 2026-05-08 | -$6.54M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-12-31 | -$2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | -$3.72M 10-Q · filed 2026-02-03 | -$2.74M derived: sum of 3 quarters · filed 2026-09-09 | -$10.88M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-09-30 | -$814.00K 10-Q · filed 2025-11-04 | $162.00K derived: sum of 2 quarters · filed 2026-09-09 | -$7.97M derived: sum of 3 quarters · filed 2026-09-09 | -$3.57M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-06-30 | $976.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | -$7.16M derived: sum of 2 quarters · filed 2026-09-09 | -$2.76M derived: sum of 3 quarters · filed 2026-09-09 | -$5.55M 10-K · filed 2026-09-09 |
| 2025-03-31 | -$8.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | -$3.74M derived: sum of 2 quarters · filed 2026-05-08 | -$6.53M 10-Q · filed 2026-05-08 | -$5.59M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $4.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $1.61M 10-Q · filed 2026-02-03 | $2.54M derived: sum of 3 quarters · filed 2026-02-03 | $1.49M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | -$2.79M 10-Q · filed 2025-11-04 | -$1.86M derived: sum of 2 quarters · filed 2025-11-04 | -$2.91M derived: sum of 3 quarters · filed 2025-11-04 | -$26.02M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $934.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | -$121.00K derived: sum of 2 quarters · filed 2025-09-09 | -$23.23M derived: sum of 3 quarters · filed 2025-09-09 | -$26.37M 10-K · filed 2025-09-09 |
| 2024-03-31 | -$1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-06 | -$24.17M derived: sum of 2 quarters · filed 2025-05-06 | -$27.31M 10-Q · filed 2025-05-06 | -$32.50M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$23.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-04 | -$26.25M 10-Q · filed 2025-02-04 | -$31.44M derived: sum of 3 quarters · filed 2025-02-04 | -$36.14M derived: sum of 4 quarters · filed 2025-02-04 |
| 2023-09-30 | -$3.14M 10-Q · filed 2024-11-05 | -$8.33M derived: sum of 2 quarters · filed 2024-11-05 | -$13.03M derived: sum of 3 quarters · filed 2024-11-05 | -$65.00M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | -$5.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | -$9.89M derived: sum of 2 quarters · filed 2024-09-10 | -$61.85M derived: sum of 3 quarters · filed 2024-09-10 | -$69.52M 10-K · filed 2024-09-10 |
| 2023-03-31 | -$4.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-07 | -$56.66M derived: sum of 2 quarters · filed 2024-05-07 | -$64.33M 10-Q · filed 2024-05-07 | -$80.99M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$51.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-06 | -$59.63M 10-Q · filed 2024-02-06 | -$76.29M derived: sum of 3 quarters · filed 2024-02-06 | -$86.19M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-09-30 | -$7.67M 10-Q · filed 2023-11-07 | -$24.33M derived: sum of 2 quarters · filed 2023-11-07 | -$34.22M derived: sum of 3 quarters · filed 2023-11-07 | -$42.86M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$16.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | -$26.56M derived: sum of 2 quarters · filed 2023-09-12 | -$35.20M derived: sum of 3 quarters · filed 2023-09-12 | -$40.24M 10-K · filed 2023-09-12 |
| 2022-03-31 | -$9.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-09 | -$18.54M derived: sum of 2 quarters · filed 2023-05-09 | -$23.58M 10-Q · filed 2023-05-09 | -$27.04M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$8.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | -$13.68M 10-Q · filed 2023-02-07 | -$17.14M derived: sum of 3 quarters · filed 2023-02-07 | -$19.76M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-09-30 | -$5.04M 10-Q · filed 2022-11-08 | -$8.50M derived: sum of 2 quarters · filed 2022-11-08 | -$11.12M derived: sum of 3 quarters · filed 2022-11-08 | -$19.95M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | -$6.08M derived: sum of 2 quarters · filed 2022-09-13 | -$14.91M derived: sum of 3 quarters · filed 2022-09-13 | -$19.54M 10-K · filed 2022-09-13 |
| 2021-03-31 | -$2.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-10 | -$11.45M derived: sum of 2 quarters · filed 2022-05-10 | -$16.08M 10-Q · filed 2022-05-10 | -$19.98M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$8.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-09 | -$13.46M 10-Q · filed 2022-02-09 | -$17.36M derived: sum of 3 quarters · filed 2022-02-09 | |
| 2020-09-30 | -$4.63M 10-Q · filed 2021-11-09 | -$8.53M derived: sum of 2 quarters · filed 2021-11-09 | ||
| 2020-06-30 | -$3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | -$11.69M 10-K · filed 2021-09-23 | ||
| 2020-03-31 | -$7.79M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |